Wall Street Analysts Think Fulcrum Therapeutics (FULC) Could Surge 58.47%: Read This Before Placing a Bet

Fulcrum Therapeutics, Inc. (FULC) closed the last trading session at $11.99, gaining 21.5% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall Street analysts are any guide. The mean price target of$ 19 indicates a 58.5% upside potential.The mean estimate comprises nine short-term price targets with a standard deviation of $6.89. While the lowest estimate of$ 7.00 indicates a 41.6% decline from the current price level, the most optimistic a ...